These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes. Westendorf AF, Bodtke A, Bednarski PJ. Dalton Trans; 2011 May 21; 40(19):5342-51. PubMed ID: 21461431 [Abstract] [Full Text] [Related]
4. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes. Choi S, Vastag L, Larrabee YC, Personick ML, Schaberg KB, Fowler BJ, Sandwick RK, Rawji G. Inorg Chem; 2008 Feb 18; 47(4):1352-60. PubMed ID: 18220340 [Abstract] [Full Text] [Related]
9. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases. Zhou L. J Phys Chem B; 2009 Feb 19; 113(7):2110-27. PubMed ID: 19173577 [Abstract] [Full Text] [Related]
10. Syntheses, characterization, and photo-hydrogen-evolving properties of tris(2,2'-bipyridine)ruthenium(II) derivatives tethered to a cis-Pt(II)Cl2 unit: insights into the structure-activity relationship. Ozawa H, Yokoyama Y, Haga MA, Sakai K. Dalton Trans; 2007 Mar 28; (12):1197-206. PubMed ID: 17353951 [Abstract] [Full Text] [Related]
11. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships. Navarro JA, Salas JM, Romero MA, Vilaplana R, Gonzalez-Vílchez F, Faure R. J Med Chem; 1998 Jan 29; 41(3):332-8. PubMed ID: 9464364 [Abstract] [Full Text] [Related]
12. Photolysis and thermolysis of platinum(IV) 2,2'-bipyridine complexes lead to identical platinum(II)-DNA adducts. Loup C, Tesouro Vallina A, Coppel Y, Létinois U, Nakabayashi Y, Meunier B, Lippert B, Pratviel G. Chemistry; 2010 Oct 04; 16(37):11420-31. PubMed ID: 20715200 [Abstract] [Full Text] [Related]
13. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines. Kratochwil NA, Bednarski PJ. Arch Pharm (Weinheim); 1999 Aug 04; 332(8):279-85. PubMed ID: 10489538 [Abstract] [Full Text] [Related]
15. Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells. Nemirovski A, Kasherman Y, Tzaraf Y, Gibson D. J Med Chem; 2007 Nov 15; 50(23):5554-6. PubMed ID: 17949066 [Abstract] [Full Text] [Related]
17. Effect of thiols exported by cancer cells on the stability and growth-inhibitory activity of Pt(IV) complexes. Kratochwil NA, Bednarski PJ. J Cancer Res Clin Oncol; 1999 Dec 15; 125(12):690-6. PubMed ID: 10592102 [Abstract] [Full Text] [Related]
18. Decomposition pathways for the photoactivated anticancer complex cis,trans,cis-[Pt(N3)2(OH)2(NH3)2]: insights from DFT calculations. Salassa L, Phillips HI, Sadler PJ. Phys Chem Chem Phys; 2009 Nov 28; 11(44):10311-6. PubMed ID: 19890514 [Abstract] [Full Text] [Related]
19. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ. Anticancer Drugs; 2009 Aug 28; 20(7):559-72. PubMed ID: 19491657 [Abstract] [Full Text] [Related]
20. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2]. Mazzega Sbovata S, Bettio F, Marzano C, Tassan A, Mozzon M, Bertani R, Benetollo F, Michelin RA. J Inorg Biochem; 2008 Apr 28; 102(4):882-91. PubMed ID: 18267343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]